Profiel
Wenpei Su is Director of Genomic Applications for CeMines, Inc. He joined CeMines in July 2004.
He is responsible for the assimilation of pure molecular and immunome research.
He has 20 years of research and product development experience.
He was Senior Staff Scientist and Project Leader of Novartis Research Institute in 1999.
He received a PhD in molecular biology and biochemistry from Cornell University in 1994.
Eerdere bekende functies van Wenpei Su
| Bedrijven | Functie | Einde |
|---|---|---|
CeMines, Inc.
 CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Corporate Officer/Principal | - |
Opleiding van Wenpei Su
| Cornell University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
CeMines, Inc.
CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Health Technology |
